Gene expression in colorectal neoplasia: Modifications induced by tissue ischaemic time and tissue handling protocol

Histopathology

Volumn 56, Issue 2, 2010, Pages 240-250

  Bray, Susan E ^a   Paulin, Fiona E M ^a   Fong, Siew Chinn ^a   Baker, Lee ^a   Carey, Frank A ^a   Levison, David A ^a   Steele, Robert J C ^a   Kernohan, Neil M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Colorectal cancer; Gene expression profiling; RNA integrity; RNA isolation; Tissue handling

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 34; KRUPPEL LIKE FACTOR 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; PROTEIN MDMX; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; COLON BIOPSY; COLON ISCHEMIA; COLORECTAL TUMOR; FEMALE; FREEZING; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GPR 34 GENE; HUMAN; HUMAN TISSUE; IGF 1 GENE; KLF 6 GENE; LABORATORY DIAGNOSIS; MALE; MAP 2 K 3 GENE; MDM 4 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECTUM BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; RNA ISOLATION; STANDARDIZATION; TISSUE PRESERVATION;

BIOPSY; COLORECTAL NEOPLASMS; CRYOPRESERVATION; FEMALE; FREEZING; GENE EXPRESSION PROFILING; HUMANS; ISCHEMIA; MALE; PROTEIN BIOSYNTHESIS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, NEOPLASM; TIME FACTORS; TISSUE FIXATION; TRANSCRIPTION, GENETIC;

EID: 73449123738     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03470.x     Document Type: Article

References (45)

1. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. Expression profiling using cDNA microarrays. Nat. Genet. 1999 21 (1 Suppl. 10 14. (Pubitemid 29031485)
2. Boyer J, Allen WL, McLean EG et al. Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. Cancer Res. 2006 66 2765 2777.
3. De Lange R, Burtscher H, Jarsch M, Weidle UH. Identification of metastasis-associated genes by transcriptional profiling of metastatic versus non-metastatic colon cancer cell lines. Anticancer Res. 2001 21 2329 2339. (Pubitemid 33054393)
4. Del Rio M, Molina F, Bascoul-Mollevi C et al. Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. J. Clin. Oncol. 2007 25 773 780.
5. Fujiwara K, Ochiai M, Ubagai T et al. Differential gene expression profiles in colon epithelium of two rat strains with distinct susceptibility to colon carcinogenesis after exposure to PhIP in combination with dietary high fat. Cancer Sci. 2003 94 672 678.
6. Li M, Lin YM, Hasegawa S et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int. J. Oncol. 2004 24 305 312.
7. Mariadason JM, Arango D, Shi Q et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res. 2003 63 8791 8812.
8. Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 2001 61 3124 3130.
9. Paoni NF, Feldman MW, Gutierrez LS, Ploplis VA, Castellino FJ. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. Physiol. Genomics 2003 15 228 235.
10. Park MH, Cho SA, Yoo KH et al. Gene expression profile related to prognosis of acute myeloid leukemia. Oncol. Rep. 2007 18 1395 1402.
11. Schmidt WM, Kalipciyan M, Dornstauder E et al. Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int. J. Cancer 2004 112 200 212.
12. Wang Y, Jatkoe T, Zhang Y et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J. Clin. Oncol. 2004 22 1564 1571.
13. Zou TT, Selaru FM, Xu Y et al. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 2002 21 4855 4862.
14. Binder R, Horowitz JA, Basilion JP, Koeller DM, Klausner RD, Harford JB. Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3′ UTR and does not involve poly(A) tail shortening. EMBO J. 1994 13 1969 1980.
15. Shyu AB, Wilkinson MF, van Hoof A. Messenger RNA regulation: to translate or to degrade. EMBO J. 2008 27 471 481.
16. Von Euler H, Khoshnoud R, He Q et al. Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures. Int. J. Mol. Med. 2005 16 979 985.
17. Akashi M, Shaw G, Hachiya M, Elstner E, Suzuki G, Koeffler P. Number and location of AUUUA motifs: role in regulating transiently expressed RNAs. Blood 1994 83 3182 3187.
18. Saida F, Odaert B. RNA recognition and cleavage by sequencespecific endoribonucleases. Protein Pept. Lett. 2007 14 103 111.
19. Wennborg A, Sohlberg B, Angerer D, Klein G, von Gabain A. A human RNase E-like activity that cleaves RNA sequences involved in mRNA stability control. Proc. Natl Acad. Sci. USA 1995 92 7322 7326.
20. Wreschner DH, Rechavi G. Differential mRNA stability to reticulocyte ribonucleases correlates with 3′ non-coding (U)nA sequences. Eur. J. Biochem. 1988 172 333 340.
21. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979 18 5294 5299.
22. Benjamin D, Moroni C. mRNA stability and cancer: an emerging link? Expert Opin. Biol. Ther. 2007 7 1515 1529.
23. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000 100 57 70.
24. Florell SR, Coffin CM, Holden JA et al. Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol. Mod. Pathol. 2001 14 116 128.
25. Schlomm T, Nakel E, Lubke A et al. Marked gene transcript level alterations occur early during radical prostatectomy. Eur. Urol. 2008 53 333 344.
26. Holter NS, Mitra M, Maritan A, Cieplak M, Banavar JR, Fedoroff NV. Fundamental patterns underlying gene expression profiles: simplicity from complexity. Proc. Natl Acad. Sci. USA 2000 97 8409 8414.
27. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 1998 95 14863 14868.
28. Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol. Aspects Med. 2006 27 126 139.
29. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990 61 759 767.
30. Smith G, Carey FA, Beattie J et al. Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer. Proc. Natl Acad. Sci. USA 2002 99 9433 9438.
31. Micke P, Ohshima M, Tahmasebpoor S et al. Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab. Invest. 2006 86 202 211.
32. Ohashi Y, Creek KE, Pirisi L, Kalus R, Young SR. RNA degradation in human breast tissue after surgical removal: a time-course study. Exp. Mol. Pathol. 2004 77 98 103.
33. Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis E, Yeatman T. Effects of ischemia on gene expression. J. Surg. Res. 2001 99 222 227.
34. Spruessel A, Steimann G, Jung M et al. Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. BioTechniques 2004 36 1030 1037.
35. Cho YG, Choi BJ, Song JW et al. Aberrant expression of krUppel-like factor 6 protein in colorectal cancers. World J. Gastroenterol. 2006 12 2250 2253.
36. Medeiros F, Rigl CT, Anderson GG, Becker SH, Halling KC. Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities. Arch. Pathol. Lab. Med. 2007 131 1805 1816.
37. Paska C, Bogi K, Szilak L et al. Effect of formalin, acetone, and RNAlater fixatives on tissue preservation and different size amplicons by real-time PCR from paraffin-embedded tissue. Diagn. Mol. Pathol. 2004 13 234 240.
38. Chowdary D, Lathrop J, Skelton J et al. Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative. J. Mol. Diagn. 2006 8 31 39.
39. Roos-van Groningen MC, Eikmans M, Baelde HJ, de Heer E, Bruijn JA. Improvement of extraction and processing of RNA from renal biopsies. Kidney Int. 2004 65 97 105.
40. Grotzer MA, Patti R, Geoerger B, Eggert A, Chou TT, Phillips PC. Biological stability of RNA isolated from RNAlater-treated brain tumor and neuroblastoma xenografts. Med. Pediatr. Oncol. 2000 34 438 442.
41. Mutter GL, Zahrieh D, Liu C et al. Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarrays. BMC Genomics 2004 5 88.
42. Olsvik PA, Lie KK, Hevroy EM. Do anesthetics and sampling strategies affect transcription analysis of fish tissues? BMC Mol. Biol. 2007 8 48.
43. Wang SS, Sherman ME, Rader JS, Carreon J, Schiffman M, Baker CC. Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation. Diagn. Mol. Pathol. 2006 15 144 148.
44. Morrison C, Palatini J, Riggenbach J, Radmacher M, Porcu P. Fine-needle aspiration biopsy of non-Hodgkin lymphoma for use in expression microarray analysis. Cancer 2006 108 311 318.
45. Sambrook J, Fritsch EF, Maniatis T. Extraction, purification and analysis of messenger RNA from eukaryotic cells. In Nolan C ed. Molecular cloning: a laboratory manual, 2nd edn. New York : Cold Spring Harbor Laboratory Press, 1989 7.1 7.87.